Skip to content

Faith Moves Mountains: An Appalachian Cervical Cancer Prevention Project

An Appalachian Cervical Cancer Prevention Project

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01372241
Acronym
FMM
Enrollment
345
Registered
2011-06-13
Start date
2005-12-31
Completion date
2009-08-31
Last updated
2017-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Keywords

Papanicolaou test, Cervical cancer screening, Randomized controlled trial, Faith-placed, Appalachia

Brief summary

The purpose of this study is to determine whether a faith-placed lay health advisor intervention is effective in increasing use of Pap smears among middle-aged and older Appalachian women.

Detailed description

Project development relied on principles of community based participatory research. Participants were recruited from faith institutions in four distressed Appalachian Kentucky counties. Investigators at the University of Kentucky worked closely with local staff who implemented study procedures in the field.

Interventions

BEHAVIORALLay health advisor visits and newsletter

The focus of the intervention was on reducing participants' self-identified barriers to obtaining Pap tests.

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Nancy Schoenberg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* Outside of cervical cancer screening guidelines at the time of study initiation * Able to provide informed consent

Exclusion criteria

* History of cervical cancer * History of hysterectomy

Design outcomes

Primary

MeasureTime frameDescription
Proportion of participants self-reporting receipt of Pap testOne month post-interventionThis measure is obtained at multiple timepoints during the study, but as the primary outcome it will be analyzed at the timepoint one month following the Early Intervention group's completion of the intervention.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026